A Baron

Assessment of the biological and pharmacological effects of the alpha nu beta3 and alpha nu beta5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors.

A. Baron, D. McConkey, D. Gustafson, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.

F. Hirsch, P. Bunn, W. Franklin, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.